Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?

Aliment Pharmacol Ther. 2005 Mar:21 Suppl 1:7-8, 21-4. doi: 10.1111/j.1365-2036.2004.02347.x.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Cardiovascular Diseases / prevention & control*
  • Colorectal Neoplasms / prevention & control
  • Esophageal Neoplasms / prevention & control
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Proton Pump Inhibitors*
  • Risk Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Proton Pump Inhibitors
  • Aspirin